• Product NameZalcitabine
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityZalcitabine(Dideoxycytidine;ddC; 2',3'-Dideoxycytidine) is a nucleoside analog reverse transcriptase inhibitor (NRTI); Zalcitabine is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase.
• Target NameHIV Protease inhibitor
• CAS No. 7481-89-2
• Calculated MW 211.22
• Formulation C9H13N3O3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HIV
  Boling pt:415C
  Melting pt:217-218C
  Solubility:Water: 42 mg/mL (198.84 mM); DMSO: 42 mg/mL (198.84 mM)
  Appearance:White Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Devineni D, Gallo JM. Clin Pharmacokinet. 1995 May;28(5):351-60.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting